[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"The International FOP Association\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":62},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":4,"maxAge":4,"enrollmentInfo":17,"targetDuration":20,"studyType":21,"phases":4,"briefSummary":22,"conditions":23,"keywords":25,"overallStatus":50,"whyStopped":4,"lastUpdateSubmitDate":51,"lastUpdatePostDateStruct":52,"startDateStruct":55,"completionDateStruct":57,"leadSponsor":59,"locationsCount":5},"100266237","the-fibrodysplasia-ossificans-progressiva-fop-registry-100266237",false,"NCT02745158","The Fibrodysplasia Ossificans Progressiva (FOP) Registry","FOP Registry: A Global Registry for the Fibrodysplasia Ossificans Progressiva Community","Inclusion Criteria:\n\n* Participants must have a confirmed diagnosis of FOP.\n* Participants (or a parent or legal guardian) must be willing and able to provide written informed consent.\n\nExclusion Criteria:\n\n* There are no exclusion criteria.","ALL",{"count":18,"type":19},800,"ESTIMATED","20 Years","OBSERVATIONAL","The Fibrodysplasia Ossificans Progressiva (FOP) Registry is a global, non-interventional, voluntary database that captures demographic and disease data directly from FOP patients and their caregivers via a secure, web-based patient portal. A physician portal (in development) will allow physicians to enter clinical data about their patients. The objectives are to organize the international FOP community for participation in clinical trials; to enable FOP patients worldwide to report data in a shared forum; to improve the collective understanding of FOP natural history; and to advance the understanding of FOP treatment outcomes.",[24],"Fibrodysplasia Ossificans Progressiva (FOP)",[26,27,28,29,30,31,32,33,34,35,36,37,38,39,40,41,42,43,44,45,46,47,48,49],"Fibrodysplasia ossificans progressiva","FOP","International FOP Association","Patient Advocacy Group","Patient Registry","Natural History","Patient-Reported Outcomes","Observational Database","Bone Morphogenetic Protein","BMP","Bone Growth","Joint","Mobility","Flare-Up","Heterotopic Ossification","Ectopic Bone","Osteochondroma","Hallux Valgus","ALK2","ACVR1","Activin A","IFOPA","Activin A Receptor Type I","Activin Receptor-like Kinase-2","RECRUITING","2026-04-02",{"date":53,"type":54},"2026-04-08","ACTUAL",{"date":56,"type":54},"2015-07",{"date":58,"type":19},"2040-12-31",{"name":60,"class":61},"The International FOP Association","OTHER",""]